Literature DB >> 9190938

The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression.

M Reichel1, B H Nelson, P D Greenberg, P B Rothman.   

Abstract

The common gamma-chain (gamma(c)) is a functional component of the IL-4R, yet cells lacking gamma(c) are able to respond to IL-4. This has led to the suggestion that a surrogate gamma'-chain, which can interact with the IL-4R alpha chain to mediate signaling, is expressed on cells lacking gamma(c). An alternative possibility is that in the absence of gamma(c), the IL-4R alpha chain is able to transduce signals by homodimerization. To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated. Treatment of cells expressing the chimeric receptor kit/IL-4R alpha with SCF induces activation of the IL-4R alpha-associated kinase JAK-1 and the transcription factor STAT6. However, tyrosine phosphorylation of JAK-3, which associates with gamma(c), is not induced by SCF in these cells. SCF-mediated ligation of kit/IL-4R alpha is sufficient to elicit IL-4-specific gene expression, including up-regulation of CD23 and synthesis of germ-line epsilon transcripts. In the T cell line CTLL2, ligation of kit/IL-4R alpha induces cellular proliferation. Finally, in JAK-1-deficient HeLa cells, STAT6 activation by IL-4 is completely abolished. Together, these data demonstrate that the IL-4R alpha cytoplasmic domain is sufficient to activate JAK-1 and STAT6 and to induce expression of IL-4 target genes, thus identifying a mechanism by which IL-4 signaling can proceed in the absence of JAK-3 and gamma(c).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9190938

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Quantitative proteomics reveals GIMAP family proteins 1 and 4 to be differentially regulated during human T helper cell differentiation.

Authors:  Jan-Jonas Filén; Sanna Filén; Robert Moulder; Soile Tuomela; Helena Ahlfors; Anne West; Petri Kouvonen; Suvi Kantola; Mari Björkman; Mikko Katajamaa; Omid Rasool; Tuula A Nyman; Riitta Lahesmaa
Journal:  Mol Cell Proteomics       Date:  2008-08-12       Impact factor: 5.911

2.  Activation of the STAT6 transcription factor in Jurkat T-cells by the herpesvirus saimiri Tip protein.

Authors:  Yuri Kim; Eun-Kyung Kwon; Ju-Hong Jeon; Insuk So; In-Gyu Kim; Myung-Sik Choi; Ik-Sang Kim; Joong-Kook Choi; Jae Ung Jung; Nam-Hyuk Cho
Journal:  J Gen Virol       Date:  2011-10-19       Impact factor: 3.891

3.  Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice.

Authors:  B Lu; C Ebensperger; Z Dembic; Y Wang; M Kvatyuk; T Lu; R L Coffman; S Pestka; P B Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

4.  Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

Authors:  C Doucet; D Brouty-Boyé; C Pottin-Clémenceau; G W Canonica; C Jasmin; B Azzarone
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

5.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Authors:  Fumihiko Ishikawa; Masaki Yasukawa; Bonnie Lyons; Shuro Yoshida; Toshihiro Miyamoto; Goichi Yoshimoto; Takeshi Watanabe; Koichi Akashi; Leonard D Shultz; Mine Harada
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

6.  STAT6-deficient mice exhibit normal induction of murine AIDS and expression of immunoglobulin E following infection with LP-BM5 murine leukemia viruses.

Authors:  H C Morse; T McCarty; N A Giese; L Taddesse-Heath; M J Grusby
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 7.  CD23 shedding: requirements for substrate recognition and inhibition by dipeptide hydroxamic acids.

Authors:  R J Mayer; P L Flamberg; S R Katchur; B J Bolognese; D G Smith; A E Marolewski; L A Marshall; A Faller
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

Review 8.  The transcriptional regulator NFIL3 controls IgE production.

Authors:  Paul B Rothman
Journal:  Trans Am Clin Climatol Assoc       Date:  2010

9.  Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction.

Authors:  J A Losman; X P Chen; D Hilton; P Rothman
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

10.  Targeted inactivation of the IL-4 receptor alpha chain I4R motif promotes allergic airway inflammation.

Authors:  Frank Blaeser; Paul J Bryce; Nga Ho; Vidya Raman; Fatma Dedeoglu; Debra D Donaldson; Raif S Geha; Hans C Oettgen; Talal A Chatila
Journal:  J Exp Med       Date:  2003-10-13       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.